PRESS Release OSSEAN
The scientifically-confirmed, DNA expression-altering OSSEAN®, developed by Boca Raton, Fla.-based
Intra-Lock®, International, Inc., dramatically improves implant healing
BOCA RATON, Fla.
(June 9, 2014) – As reported in the internationally renowned scientific journal, Bone [in
press for Aug. 2014], a research team from New York University has confirmed what scientific developers at
Intra-Lock® International, Inc. have known for several years: the fractal, nano-rough OSSEAN® surface
developed for their dental implants actually changes the cellular genetic expression – or the fate of stem cells – at
the nano-level, which in turn induces faster healing of implants.
Intra-Lock Files Suit to Protect Consumers from Unapproved Dental Device
On July 14, 2014, Intra-Lock® International, Inc. filed a lawsuit against Joseph Choukroun, his company Process for PRF, SARL (France), and a series of U.S.-based distributors that sell Choukroun’s medical device kit for the production of platelet-rich fibrin (PRF). The lawsuit alleges that the Choukroun kit that is marketed as A-PRF is a Class II medical device that is not cleared for sale in the U.S. All Class II medical devices require premarket clearance from the Food and Drug Administration (FDA) before they can be sold in the U.S.
Intra-Lock® International has received premarket clearance from FDA for its PRF production system known as the IntraSpinTM System. To date, the IntraSpinTM System is the only system for production of PRF cleared for sale by the FDA. It is important that all dentists using PRF in their practices use a system that has been evaluated and cleared by FDA, as the PRF system takes a patient’s blood, isolates the platelet-rich fibrin and then re-inserts the biological material into an open wound in a patient’s mouth. If that system does not have the types of design and quality controls, sanitation instructions or materials that FDA requires, a dentist could be endangering his patient’s wellbeing.
Intra-Lock® initiated legal action to protect consumers from potentially unsafe PRF systems and dentists from the potential liability associated with using Class II devices that have not been cleared by the FDA. Intra-Lock® International’s FDA-cleared IntraSpinTM System is available not only in the U.S., but also in many European and Asian countries.
Intra-Lock® International Inc., headquartered in Boca Raton, Florida, USA, is a leading provider of innovative dental restoration solutions including a wide range of dental implants, bio-materials and prosthetic abutments. Intra-Lock dental implants are biologically driven in design. Their architectures are “site-specific,” which encourages physiologic harmony and ensures an ideal tissue response when compromised bone volume, density and/or extraction site defects are encountered. Intra-Lock’s advanced bioactive surface, OSSEAN®, its ergonomic delivery technology, Drive-Lock™ and its exceptional abutment stability offer a complete solution for dental implant specialists. In addition, Intra-lock’s FDA cleared Intra-Spin™ System is designed to enable an efficient, cost effective and simple chairside protocol for the fabrication of one of the most exciting tools in regenerative medicine, L-PRF (Leukocyte- and Platelet- Rich Fibrin). For more information, please visit our informative website
877 330 0338
Introduction of the IntraSpin™ System
Intra-Lock® International, Inc., Boca Raton, Florida, a U.S. manufacturer, announces the introduction of the IntraSpin™ System for the safe and rapid preparation of autologous leukocyte-platelet rich fibrin (L-PRF). L-PRF is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics. It is indicated but not limited to extraction sockets, sinus and dental ridge augmentation procedures, palatal defects and maxillary bone atrophy.
L-PRF can be easily fabricated chairside by using the FDA cleared Intra- Spin™ System and a simple protocol. Every component of the Intra-Spin™ System, including the Xpressions™ Fabrication Kit (U.S. Patent Pending), has been optimized to ensure proper biocompatibility and clinical performance for graft delivery.
877 330 0338
PRESS Release Dentium Lawsuit
Intra-Lock® aggressively enforces its intellectual property rights. In June 2012, Intra-Lock filed a lawsuit in U.S. Federal Court against Korean dental implant manufacturer Dentium Co. Ltd. and it's North American subsidiary Dentium USA. In the lawsuit, Intra-Lock® alleged infringement of an Intra-Lock patent by an implant system that Dentium was offering for sale in the United States. Intra-Lock® has agreed to dismiss the lawsuit in return for Dentium's agreement not to sell the alleged infringing implant system in the United States.
Intra-Lock® will continue its policy of defending its innovations by enforcing its patent and trademark rights in the United States and in other jurisdictions where Intra-Lock has obtained such rights.
877 330 0338
BLOSSOM Press Release
Intra-Lock® is proud to introduce BLOSSOM™, a new technology in
self-tapping screw-type dental implant architecture. This engineering
breakthrough (patent pending) eliminates the need for conventional
flutes and vents that traditionally define self-tapping implants.
Implants augmented with BLOSSOM™ self-tapping technology
feature a fully integrated tapping configuration that is distributed along
the implant. They are angled and augmented by evenly spaced,
crescent-shaped, helical cutting segments. This design is intended to
mitigate the high compressive forces that build up when conventional
tapping segments become clogged with bone debris (crowding),
which can unnecessarily increase insertion torque. BLOSSOM™ selftapping
implants continually cut through the bone with remarkable
efficiency and lower insertion torque; a result of greater cutting
efficiency, the elimination of crowding and less friction.
Reduced micro-movement is enhanced by greater intimate bone
contact, larger volume of surface area engaged with bone and
efficient tap architecture.
BLOSSOM™ technology is currently available on selected Intra-Lock
877 330 0338
PRESS Release UniHex
Intra-Lock® introduces UniHex™, an implant system featuring the clinically
proven External Hex prosthetic connection. The implant body’s macro and micro
designs are based upon many of the technological advances found in Intra-
Lock’s Internal Connection Implant System. The selection of implant
architectures are engineered to be “site-specific” and to encourage physiologic
harmony. The implants all have the biologically active surface treatment
OSSEAN®, reported in the literature to activate the body’s natural healing abilities
stimulating bone cell metabolism and encouraging accelerated healing.
Intra-Lock's UniHex™ utilizes the standard Branemark 2.7mm wide by 0.7mm tall
hex connection making it fully compatible with this most widely used prosthetic
standard. This same connection is shared by all the system’s implant
architectures; 3.4mm, 4.0mm and 4.75mm diameters. Exceptional manufacturing
quality and the strength of titanium alloy ensures a more stable external hex
connection than ever before. Intra-Lock’s Clinical Retaining Screw, characterized
by a proprietary enhanced microscopic surface structure, allows the maximum
amount of pre-stress to be applied when tightening the final restoration. This
combination of quality, strength, and technology are important factors in reducing
micro-movement, minimizing micro-leakage and avoiding screw loosening.
For the implant surgeon, this broad-based system will help ensure an ideal bone
response when compromised volume, density, and extraction site defects are
encountered. A single family of prosthetic components offer the restorative
dentist unparalleled sophistication in oral rehabilitation, with simplicity in
treatment planning and instrumentation.
877 330 0338
PRESS Release MILO
MILO® is Intra-Lock’s one-piece 3.0mm diameter dental implant system.
Engineered as a true “convertible” small diameter implant, it is endowed with
qualities that render it ideal for long-term denture stabilization or fixed prosthetic
options. Patented Cement-Over Abutments available in Straight, 15 degree,
Wide, and Castable designs simply fit over the O-Ball assembly converting the
implant from removable to fixed prosthetic options. A healing abutment is even
available as an option. The MILO® implant system also features a special
titanium abutment suitable for CAD/CAM ceramic restorations. MILO® implants
may be immediately loaded or restored after a period of time. As with MDL®
Implants, MILO® Implants feature Drive-Lock technology for mount less, efficient
placement and have the bioactive OSSEAN® surface.
877 330 0338
MDL® - Mini Drive-Lock
Intra-Lock’s MDL® small diameter dental implant system is thoughtfully
engineered to provide ergonomic efficiency, prosthetic versatility and tissue
compatibility for superior patient’s denture stability. The implants, available in 2.0
and 2.5mm diameters, are profiled for strength, stability and ease of insertion.
They feature patented Drive-Lock™ technology that optimizes single motion
delivery, from pick-up to placement. Intra-Lock’s MDL® implants are the only
small diameter implants in the world that have the bioactive OSSEAN™ surface.
877 330 0338